Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial.

Scientific reports - 21 Aug 2022

Susomboon Teerada, Kunlamas Yotsaya, Vadcharavivad Somratai, Vongwiwatana Attapong

Abstract excerpt

The objective of this study was to assess the effect of the very low dosage of diltiazem on tacrolimus exposure during the first week post-kidney transplantation, among cytochrome P450 (CYP) 3A5 expressers who did not receive diltiazem (EXplb), CYP3A5 expressers who received the very low dose diltiazem (EXdtz), CYP3A5 nonexpressers who did not receive diltiazem (NEplb), and CYP3A5 nonexpressers who received the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP3A
Share to CYP3A5 gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Tacrolimus

Source

Open in PubMed Open full text

Identifiers

PMID: 35989346
DOI: 10.1038/s41598-022-18552-7
PMCID: PMC9393165

Genes

CYP3A5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial.PMID 35989346Read ↗

Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study.Semantic proximity Read ↗

Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective.Semantic proximity Read ↗

A Simple Novel Technique to Estimate Tacrolimus Dosages During the Early Post Kidney Transplantation Period.Semantic proximity Read ↗

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial.Semantic proximity Read ↗

Effect of Wuzhi preparations on tacrolimus in CYP3A5 expressers during the early period after transplantation: A real-life experience from heart transplant recipients.Semantic proximity Read ↗

Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation.Semantic proximity Read ↗

Pharmacokinetic and CYP3A5 pharmacogenetic differences between once- and twice-daily tacrolimus from the first dosing day to 1 year after renal transplantation.Semantic proximity Read ↗

Pharmacokinetic Evaluation of Tacrolimus in Chinese Adult Patients Receiving Voriconazole During the Early Stage Post-Lung TransplantationSemantic proximity Read ↗

How to handle missed or delayed doses of tacrolimus in renal transplant recipients? A pharmacokinetic investigation.Semantic proximity Read ↗

Tacrolimus Concentration/Dose Ratio in Hematopoietic Cell Transplantation Recipients: An Exploratory Study of Metabolizer Phenotyping and Clinical Outcomes.Semantic proximity Read ↗

Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.Semantic proximity Read ↗

Prograf produces more benefits for CYP3A5 low expression patients in early stage after kidney transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.